phosphorus has been researched along with everolimus in 1 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (everolimus) | Trials (everolimus) | Recent Studies (post-2010) (everolimus) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 5,631 | 1,289 | 4,579 |
Protein | Taxonomy | phosphorus (IC50) | everolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 2 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, K; Aoki, J; Hibi, K; Ikari, Y; Kozuma, K; Maruyama, Y; Nasu, K; Otsuka, M; Sato, T; Tanabe, K; Uehara, Y | 1 |
1 other study(ies) available for phosphorus and everolimus
Article | Year |
---|---|
Impact of Serum Phosphorus Levels on Outcomes After Implantation of Drug-Eluting Stents in Patients on Hemodialysis.
Topics: Aged; Antineoplastic Agents; Cardiovascular Diseases; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Paclitaxel; Phosphorus; Registries; Renal Dialysis; Renal Insufficiency, Chronic; Sirolimus; Treatment Outcome | 2018 |